Dr. Chakra Pani Chaulagain, MD

Dr. Chaulagain practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Chaulagain's NPI, 1487824124, was assigned on March 10, 2008. Dr. Chaulagain graduated from Tribhuvan University Inst of Medicine in 2003. Dr. Chaulagain holds Florida license ME 119743.

Dr. Chaulagain's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Chaulagain's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Chaulagain is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Chaulagain to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chaulagain practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Chaulagain's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chaulagain is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Chaulagain's licenses on file in 4 states: Florida, Massachusetts, Illinois and Wisconsin.

Dmand AI lists chronic anemia, chronic leukemia, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Chaulagain treats.

CMS data shows 742 Medicare services from Dr. Chaulagain across 7 procedure codes in 2024, for 235 Medicare patients. Medicare paid $60,770 for them.

CMS counts 235 Medicare patients who saw Dr. Chaulagain in 2024. The largest group is 75 to 84, with 104 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chaulagain's median patient age at 70, with 46% women.

In 2024, Dr. Chaulagain wrote 1,217 Medicare Part D claims for 185 patients. 54% of them were for generic drugs. CMS names the drug for 970 of them, across 28 drugs with 11 or more claims each, at $9,799,489 in total drug cost. In 2023, CMS named 861 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Chaulagain for performance year 2024, reported through an alternative payment model (APM). Dr. Chaulagain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chaulagain as offering telehealth.

Dmand AI links 46 papers to Dr. Chaulagain, published from 2013 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Multiple Myeloma, Amyloidosis and Hematopoietic Stem Cell Transplantation. Dr. Chaulagain has published most often in Clin Lymphoma Myeloma Leuk. Dr. Chaulagain's most frequent co-authors are Faiz Anwer, MD, Raymond L. Comenzo, MD and Christy Joy Samaras, DO.

Dmand AI links Dr. Chaulagain to 1 clinical trial. Conditions studied include Anemia, Hemolytic, Autoimmune and Anemia, Hemolytic.

CMS Open Payments shows 421 general payments to Dr. Chaulagain from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Janssen Pharmaceuticals, Inc paid the most, $77,290.

Dmand AI lists 1 award for Dr. Chaulagain, most recently Multiple Myeloma Research Fellow Award in 2013.

Dr. Chaulagain graduated from Tribhuvan University Inst of Medicine in 2003. Dr. Chaulagain is a member of ASCO.

Dr. Chaulagain is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.